Target intelligence / Profile preview

Transmembrane protein 106A (TMEM106A)

Target
TMEM106A
Molecular classification
Other (Type II transmembrane protein; not categorized as receptor, enzyme, transporter, GPCR, or transcription factor)
01

Overview

Transmembrane protein 106A (TMEM106A) is a type II transmembrane protein encoded by the TMEM106A gene located on chromosome 17q21.31 in humans[1][2][4]. The protein is approximately 28.9 kDa in size and has 262 amino acids with a single transmembrane region and a large extracellular domain[1][2]. TMEM106A is constitutively expressed on the plasma membrane of macrophages and is implicated in the polarization of macrophages toward a pro-inflammatory (M1) state through activation of the MAPK and NF-κB signaling pathways[2][3][4]. It functions as an interferon-stimulated gene with antiviral properties, particularly by inhibiting the binding and infection of certain viruses such as Enterovirus A71 and Coxsackievirus A16, via steric hindrance at the SCARB2 receptor[2]. Beyond its antiviral roles, TMEM106A has been identified as a tumor suppressor gene with reduced expression in some cancers, such as gastric cancer[2][3]. It is highly conserved among mammals, suggesting a fundamental biological role[2][3].

Other names
MGC20235TMEM106A
02

Biological functions

Immune response (macrophage activation and M1 polarization)Antiviral defense (inhibition of certain viral infections, especially enteroviruses and HIV-1)Signal transduction (involvement in MAPK and NF-κB signaling)
03

Disease associations

Cancer (tumor suppressor in gastric cancer; downregulated in some cancers)Infection (host antiviral defense against specific viruses, e.g., Enterovirus A71, HIV-1)Neurodegenerative disease (potential links to frontotemporal dementia and/or amyotrophic lateral sclerosis 7)

Beyond the preview

Go deeper on Transmembrane protein 106A (TMEM106A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protein 106A (TMEM106A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call